Endocan: A new marker for cancer and a target for cancer therapy (Review)

  • Authors:
    • Jinghui Yang
    • Qiwei Yang
    • Shan Yu
    • Xuewen Zhang
  • View Affiliations

  • Published online on: February 26, 2015     https://doi.org/10.3892/br.2015.438
  • Pages: 279-283
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Endocan, previously known as endothelial cell‑specific molecule‑1 (ESM‑1), was cloned from the human umbilical vein endothelial cell cDNA library. Endocan is a novel ESM, and a 50 kDa soluble proteoglycan. Endocan is secreted into the blood as the soluble proteoglycan, which is the form in the presence of chondroitin sulfate. In normal tissues, chondroitin sulfate/dermatan sulfate proteoglycan is expressed by endothelial cells (such as lung and kidney) and is overexpressed in several carcinoma endothelial cells. There are studies that identified high endocan expression in lung cancer, uterine cancer, kidney cancer, liver cancer, brain glioblastoma, breast cancer and other tumors. Tumor prognosis, metastasis and angiogenesis were shown to be associated with endocan expression. The majority of investigators believe that endocan regulates the tumor by tumor‑associated inflammation, angiogenesis, lymphangiogenesis, the tumor cells themselves and other aspects. Endocan may be a new target for cancer therapy.
View Figures
View References

Related Articles

Journal Cover

May 2015
Volume 3 Issue 3

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Yang, J., Yang, Q., Yu, S., & Zhang, X. (2015). Endocan: A new marker for cancer and a target for cancer therapy (Review). Biomedical Reports, 3, 279-283. https://doi.org/10.3892/br.2015.438
MLA
Yang, J., Yang, Q., Yu, S., Zhang, X."Endocan: A new marker for cancer and a target for cancer therapy (Review)". Biomedical Reports 3.3 (2015): 279-283.
Chicago
Yang, J., Yang, Q., Yu, S., Zhang, X."Endocan: A new marker for cancer and a target for cancer therapy (Review)". Biomedical Reports 3, no. 3 (2015): 279-283. https://doi.org/10.3892/br.2015.438